首页> 外国专利> CRISPR-CAS NUCLEASES FROM CPR-ENRICHED METAGENOME

CRISPR-CAS NUCLEASES FROM CPR-ENRICHED METAGENOME

机译:CPR-CAS来自CPR的CAS核酸酶来自CPR-富集

摘要

The present invention relates to a nucleic acid molecule encoding an RNA-guided DNA endonuclease, which is (a) a nucleic acid molecule encoding the RNA-guided DNA endonuclease comprising or consisting of the amino acid sequence of SEQ ID NO: 1 or 3; (b) a nucleic acid molecule comprising or consisting of the nucleotide sequence of SEQ ID NO: 2 or 4; (c) a nucleic acid molecule encoding a RNA-guided DNA endonuclease the amino acid sequence of which is at least 70 % identical to the amino acid sequence of (a); preferably at least 80 % identical, more preferably at least 90 % identical, and most preferred at least 95% identical; (d) a nucleic acid molecule comprising or consisting of a nucleotide sequence which is at least 70 % identical to the nucleotide sequence of (b), preferably at least 80 % identical, more preferably at least 90 % identical, and most preferred at least 95% identical; (e) a nucleic acid molecule which is degenerate with respect to the nucleic acid molecule of (d); or (f) a nucleic acid molecule corresponding to the nucleic acid molecule of any one of (a) to (d) wherein T is replaced by U.
机译:本发明涉及编码RNA引导的DNA内切核酸酶的核酸分子,其是(a)编码包含或由SEQ ID NO:1或3的氨基酸序列组成的RNA引导的DNA内切核酸酶的核酸分子; (b)包含或由SEQ ID NO:2或4的核苷酸序列组成的核酸分子; (c)编码RNA引导的DNA内切核酸酶的核酸分子,其氨基酸序列与(a)的氨基酸序列相同的至少70%;优选地,至少80%相同,更优选至少90%相同,最优选的至少95%相同; (d)包含或由核苷酸分子组成的核酸分子,其与(b)的核苷酸序列相同的至少70%,优选至少80%相同,更优选至少90%相同,并且最优选95%相同; (e)关于(d)的核酸分子来退化的核酸分子; (f)(f)与(a)至(d)中任一项的核酸分子对应的核酸分子,其中T被U替换为U.

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号